Response Biomedical's Q1 Revenues Jump 67 Percent

A restructuring effort announced in September has reduced costs while a focus on the firm's cardiac business has increased sales volume, its CEO said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories